Partner Content Partner Content 3rd Donor Selection & Cell Source Summit Transforming Off-The-Shelf Therapies From the Start
Partner Content Partner Content LEAP TA: Life Sciences Reimagine Hiring Tactics to Compete for the Best Life Sciences Talent
Partner Content Partner Content MASH Drug Development Summit Advancing Efficacious MASH Therapeutics in the Evolving Metabolic Landscape
Partner Content Partner Content 2nd World Companion Diagnostics & Liquid Biopsy Summit APAC The Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies
Partner Content Partner Content 10th CAR-TCR Summit – A Decade of Engineering a Disease-Free... It's a pivotal moment for cell therapy. New trials, breakthrough data, major acquisitions and regulatory shifts are transforming the landscape...
Partner Content Partner Content LEAN Cell & Gene Summit Boston Manufacturing Advanced Therapies Just in Time for All Patients
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
